Skip to main content
. 2013 Jan 29;28(2):220–226. doi: 10.3346/jkms.2013.28.2.220

Table 1.

Patient characteristics

graphic file with name jkms-28-220-i001.jpg

HDCT, high-dose chemotherapy; CEC, carboplatin + etoposide + cyclophosphamide; CTE, carboplatin + thiotepa + etoposide; CEM, carboplatin + etoposide + melphalan; CEM-TBI, CEM + total-body irradiation; CM, cyclophosphamide + melphalan; BM, busulfan + melphalan; TM, thiotepa + melphalan; CTM, carboplatin + TM; MIBG-TM, 131I-metaiodobenzylguanidine treatment + TM.